Company / EPS (Diluted)
Amgen EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$12.49
FY2025
5-year range
$10.28 / $12.88
FY2021-FY2025
Trend
+3.1%
vs FY2024
Sector context
#6 of 204
Health Care
What the data says
Among 204 Health Care companies, Amgen is in the top 3% for eps (diluted). EPS (Diluted) has fluctuated over the past 10 years, ranging from $2.69 in FY2019 to $12.88 in FY2021.
Based on SEC 10-K filings.
12.49 in FY2025 with a 5-year CAGR of -0.2%. Top quartile in the Health Care sector.
Improved from $10.28 to $12.49 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +0.5%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 204This company $12.49 Sector average -$1.03
▼
+1310.4% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 3.1% year-over-year.
- Ranks #6 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.49 | +3.1% |
| FY2024 | $12.11 | +17.8% |
| FY2023 | $10.28 | -16.5% |
| FY2022 | $12.31 | -4.4% |
| FY2021 | $12.88 | +2.1% |
| FY2020 | $12.62 | +369.1% |
| FY2019 | $2.69 | -73.7% |
| FY2018 | $10.24 | +13.0% |
| FY2017 | $9.06 | +35.2% |
| FY2016 | $6.70 | +0.9% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026